These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1458370)

  • 1. Prevention of 5-fluorouracil-induced infection with indigenous Escherichia coli in tumor-bearing mice by nonspecific immunostimulation.
    Nomoto K; Yokokura T; Nomoto K
    Can J Microbiol; 1992 Aug; 38(8):774-8. PubMed ID: 1458370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of indigenous infection of mice with Escherichia coli by nonspecific immunostimulation.
    Nomoto K; Yokokura T; Mitsuyama M; Yoshikai Y; Nomoto K
    Antimicrob Agents Chemother; 1992 Feb; 36(2):361-7. PubMed ID: 1605602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of lethal infection with indigenous Escherichia coli in mice by fluorouracil.
    Nomoto K; Yokokura T; Yoshikai Y; Mitsuyama M; Nomoto K
    Can J Microbiol; 1991 Mar; 37(3):244-7. PubMed ID: 1829022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice.
    Kato I; Yokokura T; Mutai M
    Cancer Immunol Immunother; 1988; 26(3):215-21. PubMed ID: 3133111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.
    Yu M; Qi R; Chen C; Yin J; Ma S; Shi W; Wu Y; Ge J; Jiang Y; Tang L; Xu Y; Li Y
    J Appl Microbiol; 2017 Feb; 122(2):506-515. PubMed ID: 27860074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tumor necrosis factor (TNF)-alpha in the antitumor effect of intrapleural injection of Lactobacillus casei strain Shirota in mice.
    Yasutake N; Matsuzaki T; Kimura K; Hashimoto S; Yokokura T; Yoshikai Y
    Med Microbiol Immunol; 1999 Aug; 188(1):9-14. PubMed ID: 10691088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on antitumor activity and cytokine production in the thoracic cavity by intrapleural administration of Lactobacillus casei in tumor-bearing mice.
    Matsuzaki T; Hashimoto S; Yokokura T
    Med Microbiol Immunol; 1996 Nov; 185(3):157-61. PubMed ID: 9007821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Augmentation of antitumor activity of Lactobacillus casei YIT 8018 (LC 9018) in combination with various antitumor drugs].
    Matsuzaki T; Kato I; Yokokura T; Mutai M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):445-51. PubMed ID: 6200079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of 987P fimbriae of enterotoxigenic Escherichia coli surface-displayed on Lactobacillus casei.
    Bai Y; Wang G; Qi H; Wang Y; Xu C; Yue L; Hou X; Yu L
    Res Vet Sci; 2020 Feb; 128():308-314. PubMed ID: 31901569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of mice against herpes simplex virus infection by a Lactobacillus casei preparation (LC 9018) in combination with inactivated viral antigen.
    Watanabe T; Saito H
    Microbiol Immunol; 1986; 30(2):111-22. PubMed ID: 3012292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model.
    Nomoto K; Matsuoka Y; Hayakawa K; Ohwaki M; Kan T; Yoshikai Y; Nomoto K
    Med Microbiol Immunol; 1992; 181(2):87-98. PubMed ID: 1406460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host-mediated antitumor activity of Lactobacillus casei in mice.
    Yasutake N; Kato I; Ohwaki M; Yokokura T; Mutai M
    Gan; 1984 Jan; 75(1):72-80. PubMed ID: 6427051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice.
    Miake S; Nomoto K; Yokokura T; Yoshikai Y; Mutai M; Nomoto K
    Infect Immun; 1985 May; 48(2):480-5. PubMed ID: 3921464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen radical production by peritoneal macrophages and Kupffer cells elicited with Lactobacillus casei.
    Hashimoto S; Nomoto K; Matsuzaki T; Yokokura T; Mutai M
    Infect Immun; 1984 Apr; 44(1):61-7. PubMed ID: 6423544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of a recombinant and a mutein type of granulocyte colony stimulating factor on the growth of Meth-A fibrosarcoma with 5-fluorouracil chemotherapy.
    Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Masai Y; Fukumoto M; Tobe T
    Biotherapy; 1992; 4(2):81-6. PubMed ID: 1377928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei.
    Yokokura T; Nomoto K; Shimizu T; Nomoto K
    Infect Immun; 1986 Apr; 52(1):156-60. PubMed ID: 3082755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of tumoricidal peritoneal exudate cells by administration of Lactobacillus casei.
    Kato I; Yokokura T; Mutai M
    Int J Immunopharmacol; 1985; 7(1):103-9. PubMed ID: 3158616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein.
    Liu JK; Hou XL; Wei CH; Yu LY; He XJ; Wang GH; Lee JS; Kim CJ
    Appl Environ Microbiol; 2009 Jul; 75(13):4491-7. PubMed ID: 19447955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.
    Wen LJ; Hou XL; Wang GH; Yu LY; Wei XM; Liu JK; Liu Q; Wei CH
    Vaccine; 2012 May; 30(22):3339-49. PubMed ID: 21856357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antitumor activity of Lactobacillus casei with other bacterial immunopotentiators.
    Yasutake N; Ohwaki M; Yokokura T; Mutai M
    Med Microbiol Immunol; 1984; 173(3):113-25. PubMed ID: 6438456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.